Positive Results in Late-Stage Trial for Lung Cancer Treatment
Eli Lilly & Co. (LLY) has reported significant progress in a Phase 3 clinical trial of their treatment for a specific type of non-small cell lung cancer. The trial, called…
Eli Lilly & Co. (LLY) has reported significant progress in a Phase 3 clinical trial of their treatment for a specific type of non-small cell lung cancer. The trial, called…